Dr. Laila I. Muderspach, MD

Dr. Muderspach practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Muderspach's NPI, 1306841648, was assigned on June 14, 2005. Dr. Muderspach graduated from Loma Linda University School Of Medicine in 1985. Dr. Muderspach's California license number on file is G57989.

Dr. Muderspach's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Muderspach's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Muderspach is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Muderspach to 1 more physician office, 1 group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muderspach practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Muderspach's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Muderspach is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Muderspach has a license on file in California.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Muderspach treats.

CMS data shows 56 Medicare services from Dr. Muderspach across 1 procedure code in 2024, all of them office visits, for 49 Medicare patients. Medicare paid $2,796 for them.

CMS counts 49 Medicare patients who saw Dr. Muderspach in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muderspach's median patient age at 63, with 99% women.

In 2024, Dr. Muderspach wrote 67 Medicare Part D claims for 17 patients. 72% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $851 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Muderspach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Muderspach, published from 2011 to 2025. 2012 was the busiest year, with 3. Dr. Muderspach's most frequent co-authors are Lynda D. Roman, MD, Koji Matsuo, MD and Sigita Susan Cahoon, MD.

CMS Open Payments shows 1 general payment to Dr. Muderspach from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Myriad Genetic Laboratories, Inc. paid the most, $16.

Dmand AI lists 2 awards for Dr. Muderspach.

Dr. Muderspach graduated from Loma Linda University School Of Medicine in 1985. Dr. Muderspach is a member of American College of Obstetricians and Gynecologists.

Dr. Muderspach is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.